Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Nature Communications
|
March 14, 2026
Shear properties and stable wrinkle resistance in 2D Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXene monolayers
Chao Rong, Ting Su, Tianhao Yu, et al.
Nano Letters
|
July 29, 2024
High-Density Dual-Structure Single-Atom Pt Electrocatalyst for Efficient Hydrogen Evolution and Multimodal Sensing
Tianshu Chu, Guiying Wang, Xiangyu Zhang, et al.
BMC Chemistry
|
March 11, 2025
Theoretical study on the alkyl chain length impact of azobenzene-based photoresponsive ionic liquids
Liyao Ying, Zhaoyang Ju, Chunjin Lin, et al.
BMC Palliative Care
|
April 25, 2023
Attitudes and influencing factors of nursing assistants towards hospice and palliative care nursing in chinese nursing homes: a cross-sectional study
Zhuojun Ye, Limei Jing, Haoyu Zhang, et al.
Frontiers in Public Health
|
June 5, 2023
Nurses' practices and their influencing factors in palliative care
Yifan Xu, Shiwen Zhang, Jingrong Wang, et al.
Journal of Colloid and Interface Science
|
July 7, 2014
Removal of nitric oxide by the highly reactive anatase TiO2 (001) surface: a density functional theory study
Wenwen Zhao, Feng Hui Tian, Xiaobin Wang, et al.
Journal of Translational Medicine
|
January 22, 2025
Firsekibart in acute gouty arthritis
Yu Xue, Tianshu Chu, Jiankang Hu, et al.
Nature Communications
|
December 14, 2023
Elucidating the structure-stability relationship of Cu single-atom catalysts using operando surface-enhanced infrared absorption spectroscopy
Li Zhang, Xiaoju Yang, Qing Yuan, et al.
Advances in Therapy
|
May 19, 2026
Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 Trial
Zaihua Zhu, Yu Xue, Tianshu Chu, et al.
Innovation (Cambridge (Mass.))
|
August 15, 2025
Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial
Yu Xue, Tianshu Chu, Jiankang Hu, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Nature Communications
|
March 14, 2026
Shear properties and stable wrinkle resistance in 2D Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXene monolayers
Chao Rong, Ting Su, Tianhao Yu, et al.
Nano Letters
|
July 29, 2024
High-Density Dual-Structure Single-Atom Pt Electrocatalyst for Efficient Hydrogen Evolution and Multimodal Sensing
Tianshu Chu, Guiying Wang, Xiangyu Zhang, et al.
BMC Chemistry
|
March 11, 2025
Theoretical study on the alkyl chain length impact of azobenzene-based photoresponsive ionic liquids
Liyao Ying, Zhaoyang Ju, Chunjin Lin, et al.
BMC Palliative Care
|
April 25, 2023
Attitudes and influencing factors of nursing assistants towards hospice and palliative care nursing in chinese nursing homes: a cross-sectional study
Zhuojun Ye, Limei Jing, Haoyu Zhang, et al.
Frontiers in Public Health
|
June 5, 2023
Nurses' practices and their influencing factors in palliative care
Yifan Xu, Shiwen Zhang, Jingrong Wang, et al.
Journal of Colloid and Interface Science
|
July 7, 2014
Removal of nitric oxide by the highly reactive anatase TiO2 (001) surface: a density functional theory study
Wenwen Zhao, Feng Hui Tian, Xiaobin Wang, et al.
Journal of Translational Medicine
|
January 22, 2025
Firsekibart in acute gouty arthritis
Yu Xue, Tianshu Chu, Jiankang Hu, et al.
Nature Communications
|
December 14, 2023
Elucidating the structure-stability relationship of Cu single-atom catalysts using operando surface-enhanced infrared absorption spectroscopy
Li Zhang, Xiaoju Yang, Qing Yuan, et al.
Advances in Therapy
|
May 19, 2026
Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 Trial
Zaihua Zhu, Yu Xue, Tianshu Chu, et al.
Innovation (Cambridge (Mass.))
|
August 15, 2025
Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial
Yu Xue, Tianshu Chu, Jiankang Hu, et al.
Page
of 9